Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.65% |
| 2 | Technology | 14.28% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABB
876
DELISTED
ABB Ltd
ABB
| $566K | 0.01% |
+32,797
| New | +$716K |
|
877
Piper Sandler
PIPR
$5.37B
| $564K | 0.01% |
+44,572
| New | +$794K |
|
878
Celanese
CE
$5.09B
| $563K | 0.01% |
+7,666
| New | +$758K |
|
|
ESGR
879
DELISTED
Enstar Group
ESGR
| $563K | 0.01% |
+3,539
| New | +$649K |
|
|
RETA
880
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $562K | 0.01% |
+3,895
| New | +$752K |
|
881
Greif
GEF
$5.01B
| $559K | 0.01% |
+17,968
| New | +$681K |
|
882
US Physical Therapy
USPH
$1.16B
| $559K | 0.01% |
8,103
-3,851
| -32% | -$406K |
|
|
GES
883
DELISTED
Guess Inc
GES
| $557K | 0.01% |
+82,268
| New | +$1.43M |
|
|
VISN
884
Vistance Networks Inc
VISN
$2.56B
| $551K | 0.01% |
+60,431
| New | +$702K |
|
885
AES
AES
$10.5B
| $548K | 0.01% |
+40,266
| New | +$722K |
|
|
SAGE
886
DELISTED
Sage Therapeutics
SAGE
| $547K | 0.01% |
19,038
-133,467
| -88% | -$7.73M |
|
|
PS
887
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $545K | 0.01% |
+49,672
| New | +$826K |
|
888
Patrick Industries
PATK
$2.72B
| $544K | 0.01% |
+28,965
| New | +$922K |
|
889
Chegg
CHGG
$90.3M
| $543K | 0.01% |
15,181
-15,829
| -51% | -$618K |
|
890
Sunrun
RUN
$2.17B
| $543K | 0.01% |
+53,791
| New | +$883K |
|
891
Cathay General Bancorp
CATY
$4.18B
| $542K | 0.01% |
23,596
+4,470
| +23% | +$143K |
|
892
XBiotech
XBIT
$70.7M
| $536K | 0.01% |
+50,427
| New | +$821K |
|
|
GPMT
893
Granite Point Mortgage Trust
GPMT
$54.5M
| $531K | 0.01% |
104,723
+69,457
| +197% | +$1.05M |
|
894
Pitney Bowes
PBI
$2.28B
| $525K | 0.01% |
+257,381
| New | +$883K |
|
895
Ubiquiti
UI
$32.9B
| $524K | 0.01% |
3,702
-15,029
| -80% | -$2.29M |
|
|
PGTI
896
DELISTED
PGT, Inc.
PGTI
| $522K | 0.01% |
+62,264
| New | +$885K |
|
897
Commercial Metals
CMC
$7.49B
| $521K | 0.01% |
32,994
+8,175
| +33% | +$156K |
|
|
TRHC
898
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $520K | 0.01% |
+9,936
| New | +$538K |
|
899
PUT
Deluxe
DLX
$1.1B
| $519K | 0.01% |
20,000
-4,000
| -17% | -$154K |
|
900
IDEX
IEX
$17.4B
| $519K | 0.01% |
+3,757
| New | +$589K |
|
Similar funds
Dmitry Balyasny's Q1 2020 Portfolio in Review
As of Q1 2020, Dmitry Balyasny held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
Against the trend, Dmitry Balyasny opened a new position in Lowe's Companies worth $86M.
- Dmitry Balyasny's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Dmitry Balyasny added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Dmitry Balyasny's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Dmitry Balyasny fully exited American International in Q1 2020, selling an estimated $193M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Dmitry Balyasny opened 583 new positions and closed 598 in Q1 2020.
- Dmitry Balyasny's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.